Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$2.32 - $3.68 $175,753 - $278,782
75,756 New
75,756 $190,000
Q2 2022

Aug 09, 2022

BUY
$3.76 - $6.29 $601,160 - $1.01 Million
159,883 Added 204.42%
238,095 $1.34 Million
Q1 2022

May 12, 2022

BUY
$5.03 - $9.61 $364,851 - $697,061
72,535 Added 1277.7%
78,212 $482,000
Q4 2021

Feb 10, 2022

BUY
$8.12 - $10.37 $46,097 - $58,870
5,677 New
5,677 $50,000

Others Institutions Holding CODX

About Co-Diagnostics, Inc.


  • Ticker CODX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 33,781,000
  • Market Cap $26.3M
  • Description
  • Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...
More about CODX
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.